Jade Biosciences, Inc. · NASDAQ:JBIO
Bellevue Group AG reported a 6.80% stake in Jade Biosciences, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Bellevue Group AG reported a 6.80% stake in Jade Biosciences, Inc., 4,293,937 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 6.80%
- Shares
- 4,293,937
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Bellevue Group AG | 6.80% | 4,293,937 |
| Bellevue Asset Management AG | 6.80% | 4,293,937 |
Source
Download original · View original at SEC
Related
- Jade Biosciences, Inc.
- Bellevue Group AG
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Bellevue Group AG · Feb 17, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Nov 16, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Nov 16, 2026
- Schedule 13G/A · Paradigm Biocapital Advisors LP · Nov 16, 2026
- Schedule 13G · Franklin Templeton Inc · Oct 28, 2026
- Schedule 13G · BlackRock, Inc. · Oct 27, 2026